Cargando…
The era of personalized treatments: Updates on immunotherapy within urothelial of bladder cancer
Bladder cancer is a complex disease of the urinary system with high morbidity and mortality. Recently, the introduction of immunotherapies such as immune checkpoint inhibitors (eg, programmed cell death protein 1/programmed death-ligand 1) has proven to be a reliable means of improving survival outc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527930/ https://www.ncbi.nlm.nih.gov/pubmed/36204361 http://dx.doi.org/10.1097/CU9.0000000000000133 |